Composition and method for producing an immune response against tumor-related antigens
View Patent ↗Disclosed are a novel prostatic acid phosphatase and corresponding coding region derived from mouse. Also disclosed is a method of producing an immune response against an autologous polypeptide tumor antigen by immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation.
1. An isolated polypeptide that induces an immune response to human prostatic acid phosphatase, wherein the isolated polypeptide comprises a sequence having at least 95% amino acid sequence identity to the sequence identified by SEQ ID NO:2.
2. The isolated polypeptide of claim 1 , wherein the polypeptide has the sequence of SEQ ID NO:2.
3. A method of inducing an immune response against human prostatic acid phosphatase (PAP) in a mammalian subject, comprising
administering to the subject an immunogenic dosage of a composition comprising an isolated polypeptide of claim 1 .
4. The method of claim 3 , wherein the isolated polypeptide is mouse PAP.
5. The method of claim 3 , wherein the isolated polypeptide has the amino acid sequence of SEQ ID NO:2.
6. The method of claim 3 , wherein the isolated polypeptide is produced in insect cells.